Registration Dossier

Toxicological information

Carcinogenicity

Currently viewing:

Administrative data

Description of key information

In accordance with Section 8.9.1. of Column 2 of Annex X of the REACH Regulation, the registrant proposes to waive the carcinogenicity study on the grounds that the substance does not have a widespread dispersive use and there is no evidence of frequent or long-term human exposure. Furthermore, the substance has shown no evidence of potential to cause germ cell mutagenicity nor is there evidence from the repeated dose study that the substance is able to induce hyperplasia and/or pre-neoplastic lesions.

Key value for chemical safety assessment

Carcinogenicity: via oral route

Endpoint conclusion
Endpoint conclusion:
no study available

Carcinogenicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Carcinogenicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

There is no data associated with the available studies to suggest that the substance possesses carcinogenic properties and therefore no classification is warranted.

Additional information